Reuters logo
BRIEF-Enanta Pharmaceuticals reports Q2 loss per share $0.28
May 8, 2017 / 8:07 PM / 7 months ago

BRIEF-Enanta Pharmaceuticals reports Q2 loss per share $0.28

May 8 (Reuters) - Enanta Pharmaceuticals Inc

* Enanta Pharmaceuticals reports financial results for its fiscal second quarter ended March 31, 2017

* Q2 loss per share $0.28

* Q2 revenue $9.0 million versus I/B/E/S view $9.2 million

* Q2 earnings per share view $-0.38 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below